Patents by Inventor Kristin Jarman

Kristin Jarman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070055458
    Abstract: Peptides are identified from a list of candidates using collision-induced dissociation tandem mass spectrometry data. A probabilistic model for the occurrence of spectral peaks corresponding to frequently observed partial peptide fragment ions is applied. As part of the identification procedure, a probability score is produced that indicates the likelihood of any given candidate being the correct match. The statistical significance of the score is known without necessarily having reference to the actual identity of the peptide. In one form of the invention, a genetic algorithm is applied to candidate peptides using an objective function that takes into account the number of shifted peaks appearing in the candidate spectrum relative to the test spectrum.
    Type: Application
    Filed: November 3, 2006
    Publication date: March 8, 2007
    Inventors: Kristin Jarman, William Cannon, Kenneth Jarman, Alejandro Heredia-Langner
  • Patent number: 6487523
    Abstract: A method and apparatus using a spectral analysis technique are disclosed. In one form of the invention, probabilities are selected to characterize the presence (and in another form, also a quantification of a characteristic) of peaks in an indexed data set for samples that match a reference species, and other probabilities are selected for samples that do not match the reference species. An indexed data set is acquired for a sample, and a determination is made according to techniques exemplified herein as to whether the sample matches or does not match the reference species. When quantification of peak characteristics is undertaken, the model is appropriately expanded, and the analysis accounts for the characteristic model and data. Further techniques are provided to apply the methods and apparatuses to process control, cluster analysis, hypothesis testing, analysis of variance, and other procedures involving multiple comparisons of indexed data.
    Type: Grant
    Filed: May 25, 2001
    Date of Patent: November 26, 2002
    Assignee: Battelle Memorial Institute
    Inventors: Kristin Jarman, Alan Willse, Karen Wahl, Jon Wahl
  • Publication number: 20020035449
    Abstract: A method and apparatus using a spectral analysis technique are disclosed. In one form of the invention, probabilities are selected to characterize the presence (and in another form, also a quantification of a characteristic) of peaks in an indexed data set for samples that match a reference species, and other probabilities are selected for samples that do not match the reference species. An indexed data set is acquired for a sample, and a determination is made according to techniques exemplified herein as to whether the sample matches or does not match the reference species. When quantification of peak characteristics is undertaken, the model is appropriately expanded, and the analysis accounts for the characteristic model and data. Further techniques are provided to apply the methods and apparatuses to process control, cluster analysis, hypothesis testing, analysis of variance, and other procedures involving multiple comparisons of indexed data.
    Type: Application
    Filed: May 25, 2001
    Publication date: March 21, 2002
    Inventors: Kristin Jarman, Alan Willse, Karen Wahl, Jon Wahl
  • Patent number: 5891024
    Abstract: A two-stage statistical calibration and measurement method and system is disclosed for performing photoplethysmographic measurement of blood analyte concentrations. Concentrations in a tissue sample of MetHb, O.sub.2 Hb, RHb and COHb are estimated by first estimating a concentration of MetHb (in a first stage) and subsequently, if the concentration of MetHb is within a predetermined range, then the estimated concentration of MetHb is assumed to be accurate and this estimated concentration of MetHb is utilized as a "known value" in determining the concentrations of the remaining analytes O.sub.2 Hb, RHb and COHb (in a second stage). That is, by eliminating one "unknown" from the system of equations, these remaining analytes can be calculated with increased accuracy. Each stage is performed using data obtained by transmitting light through the tissue sample (typically a finger or earlobe). The transmitted light is generated by four discrete light emitters, each emitter having a distinct spectral content.
    Type: Grant
    Filed: April 9, 1997
    Date of Patent: April 6, 1999
    Assignee: Ohmeda Inc.
    Inventors: Kristin Jarman, Jonas A. Pologe